2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS Russian patent published in 2012 - IPC C07D413/14 C07D413/12 C07D453/02 C07D451/04 C07D451/14 C07D453/06 A61K31/423 A61K31/435 A61K31/4523 A61K31/495 A61K31/496 A61K31/497 A61K31/498 A61K31/5377 A61K31/4427 A61K31/541 A61P1/08 A61P3/04 A61P17/04 A61P11/06 A61P25/08 A61P25/30 A61P25/32 A61P1/04 

Abstract RU 2448105 C2

FIELD: chemistry.

SUBSTANCE: invention relates to compounds of general formula where R1, R2 and R3 are independently selected from a group consisting of hydrogen, halogen and lower alkyl containing 1-6 carbon atoms; R4 denotes a residue given in the claim; R5 denotes hydrogen or methyl; R10 is selected from a group consisting of: (i) hydrogen; (ii) (C1-C10) alkyl; (iii) (C1-C10)alkyl, substituted with one or more substitutes independently selected from a group consisting of -N(CH3)2, morpholinyl, (C1-C4) alkoxy, hydroxyl, -CON(CH3)2 and halogen; (iv) monocyclic (C3-C8) cycloalkyl containing one N heteroatom; (v) 9-methyl-9-azabicyclo[3.3.1]nonane; (vi) phenyl; (vii) phenyl substituted with one or more (C1-C4)alkoxy; R11 is selected from a group consisting of hydrogen and (C1-C10)alkyl; or R10, R11 and a nitrogen atom with which they are bonded, together, form a nitric heterocycle or a substituted nitric heterocycle, such as given in the claim. The invention also relates to a pharmaceutical composition, having serotonin type 3 receptor modulating capacity and a method of treating a disorder which depends on serotonin type 3 receptor modulation.

EFFECT: compounds of formula II as serotonin type 3 receptor modulators.

18 cl, 1 tbl, 159 ex

Similar patents RU2448105C2

Title Year Author Number
RECEPTOR SUBTYPE-SELECTIVE AZABICYCLOALKANE DERIVATIVES 2008
  • Khehmmond Filip S.
  • Mazurov Anatolij A.
  • Sjao Jun'-Deh
  • Merti Srinivasa V.
  • Akireddi Srinivasa Rao
RU2417984C1
SPIRO-FUSED PIPERIDINE DERIVATIVES FOR APPLICATION AS INHIBITORS OF EXTERNAL MEDULLAR LAYER POTASSIUM CHANNEL 2013
  • Din Fa-Syan
  • Dun Shuchzhi
  • Fri Dzhessika
  • Gu Sin
  • Tszyan Tszinlun
  • Pasternak Aleksander
  • Tan Khajfyn
  • U. Chzhitsaj
  • Yuj Yan
  • Sudzuki Takao
RU2642066C2
TREATMENT OF NEUROLOGICAL DISORDERS 2017
  • Razho, Denis
  • Khebajzen, Paul
  • Bofil, Floran
  • Fabbro, Doriano
  • Khillman-Vyullner, Petra
  • Ngujen, Khoa Khu Fuk
  • Lesher, Volfgang
  • Brandt, Klaudiya
  • Zele, Aleksandr Markus
RU2765868C2
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF 2020
  • Du, Vu
  • Ven, Kun
  • Fu, Ivej
  • Lv, Khajbin
  • Khe, Tszinyun
  • Tsin, Dekun
  • Li, Yuj
  • Duan, Tszini
  • Li, Yun
  • Aj, Chaovu
  • Tu, Chzhilin
  • Chen, Yuanvej
  • Li, Sinkhaj
  • Li, Khajbo
RU2825000C2
OXADIAZOLES AS MUSCARINIC RECEPTOR AGONISTS M AND/OR M 2019
  • Brown Giles Albert
  • Teobald Barry John
  • Tehan Benjamin Gerald
RU2817018C2
PHARMACEUTICAL COMPOUNDS 2018
  • Brown Giles Albert
  • Cansfield Julie
  • Congreve Miles Stuart
  • Tehan Benjamin Gerald
  • Teobald Barry John
RU2767857C2
SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS 2013
  • Braska Mariya Gabriella
  • Bindi Simona
  • Kaldarelli Marina
  • Nezi Marchella
  • Orrenius Sten Kristian
  • Pantseri Akille
RU2666538C2
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS 2011
  • Borr'Ello Manuehla
  • Puchchi Sabrina
  • Stazi Luidzhi P'Ero
  • Rovati Luchio
RU2565596C2
NEW BIPHENYL COMPOUND OR ITS SALT 2018
  • Yamashita, Satoshi
  • Ogawa, Takahiro
RU2765152C2
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION 2018
  • Hatanaka, Ryo
RU2789449C2

RU 2 448 105 C2

Authors

Fehjrfaks Dehvid Dzh.

Jan Chzhitsaj

Dates

2012-04-20Published

2007-08-07Filed